February 21, 2019

Winner: Switchable CAR-T cell therapy
Eduardo Laborda, Ph.D., Associate Director of Immuno-oncology, Calibr

Runner-up: Unique chemical genetics-based approach
Luke Lairson, Ph.D., Assistant Professor of Chemistry

Read the Press Release